BCL2 - BCL2 apoptosis regulator Gene

Species: Macaca mulatta

Gene Type: protein coding
Gene ID: 707407

About BCL2

Primary_assembly 18: 16,792,089-16,986,217 forward strand.Mmul_10:CM014353.1

This gene has 1 transcript (splice variant), 230 orthologues and 8 paralogues.

BCL2 Products (1)

mRNA Protein Name
XM_028838050.1 XP_028693883.1 apoptosis regulator Bcl-2

BCL2 Protein Structure

bcl-2

bcl-2: TIGR00865 (0 - 240)

  • 0
  • 100
  • 200
  • 241 a.a.
Protein Preferred Names Protein Names

apoptosis regulator Bcl-2

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (19)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-15531 Venetoclax 99.95% Yes
HY-10201 Sorafenib 99.85% Yes
HY-B0011 Docetaxel 99.94% Unkown
HY-B0318 Metronidazole 99.98% Yes
HY-10201A Sorafenib tosylate 99.98% Yes
HY-148026 Sonrotoclax Inhibitor 99.61% Unkown
HY-13407 Gossypol Antagonist 99.67% Yes
HY-B0011A Docetaxel Trihydrate 99.92% Unkown
HY-B0766 Bicyclol 99.91% Unkown
HY-17510 Gossypol (acetic acid) Inhibitor 99.75% Yes
HY-B1060 Methylprednisolone succinate sodium Agonist 98.82% Yes
HY-B1065 Aceglutamide 98.0% Unkown
HY-15531R Venetoclax (Standard) 99.90% Unkown
HY-B1900 Methylprednisolone succinate 99.67% Yes
HY-W040128 Kanamycins sulfate 99.22% Unkown
HY-B0011R Docetaxel (Standard) 99.92% Unkown
HY-B0877 Halcinonide 98.29% Unkown
HY-B0420A Moroxydine hydrochloride Inhibitor 99.36% Unkown
HY-B0318A Metronidazole hydrochloride 98.44% Yes

Clinical Phase

Bioactive Molecules (32)
Cat. No. Product Name Effect
Purity Phase
HY-105930 Lobaplatin 98.0% Phase 4
HY-10087 Navitoclax Inhibitor 99.97% Phase 3
HY-N1423 Glycocholic acid 99.90% Phase 3
HY-10969 Obatoclax Mesylate 99.85% Phase 3
HY-118874A Oblimersen sodium Inhibitor 98.09% Phase 3
HY-10969A Obatoclax ≥99.0% Phase 3
HY-N0867 13-Oxyingenol-13-dodecanoate 99.37% Phase 3
HY-118874 Oblimersen / Phase 3
HY-130604 DT2216 99.97% Phase 2
HY-50868 Bafetinib 99.18% Phase 2
HY-129179 Lisaftoclax Inhibitor 99.78% Phase 2
HY-126741 Azadirachtin 99.06% Phase 2
HY-147081A AS 1411 sodium Inhibitor 99.52% Phase 2
HY-109185 Pelcitoclax 99.70% Phase 2
HY-N0068 Solasodine 99.97% Phase 2
HY-15464 (R)-(-)-Gossypol 99.37% Phase 2
HY-15464D (S)-Gossypol (acetic acid) Inhibitor 98.46% Phase 2
HY-15464A (R)-(-)-Gossypol acetic acid 98.93% Phase 2
HY-138697 S65487 99.91% Phase 2
HY-138697A S65487 sulfate 99.35% Phase 2
HY-138697B S65487 hydrochloride 98.54% Phase 2
HY-153495 Prexigebersen / Phase 2
HY-168739 Topoisomerase I inhibitor 17 / Phase 2
HY-177618 Beclanorsen Inhibitor / Phase 2
HY-177618A Beclanorsen sodium Inhibitor / Phase 2
HY-N0168 Hesperetin Modulator 99.12% Phase 1
HY-117288 S55746 Inhibitor 99.91% Phase 1
HY-155163 APG-2449 Inhibitor 98.93% Phase 1
HY-109184 Murizatoclax Inhibitor 98.84% Phase 1
HY-117288A S55746 hydrochloride Inhibitor 98.83% Phase 1
HY-168983 Lonitoclax Inhibitor / Phase 1
HY-165550 Sphingosine / Phase 1
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991883 Metuzumab / Phase 4

Pre-clinical Phase

Bioactive Molecules (467)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-50907 ABT-737 99.64% Unkown
HY-N0171A Beta-Sitosterol (purity>98%) 99.74% Unkown
HY-N0292 Oleuropein 99.97% Unkown
HY-107738 Guggulsterone 99.83% Unkown
HY-N0171 Beta-Sitosterol (purity>80%) Inducer ≥98.0% Unkown
HY-N2342 Procyanidin C1 Inducer 99.54% Unkown
HY-N0087 Gambogic Acid 98.34% Unkown
HY-W250111 Carboxymethyl chitosan 90% Unkown
HY-126477 NNK 99.97% Unkown
HY-N0361 Dihydrocapsaicin 99.93% Unkown
HY-N0674 Dehydrocorydaline 99.77% Unkown
HY-18628 UMI-77 Inhibitor 99.66% Unkown
HY-103243 TCPOBOP Inhibitor 99.70% Unkown
HY-112416 AZD4320 Inhibitor 99.66% Unkown
HY-147081 AS 1411 Inhibitor 99.52% Unkown
HY-W250122 Glutamic acid sodium salt 99.92% Unkown
HY-174228 I3IN-002 99.35% Unkown
HY-N0763 Angelicin 99.98% Unkown
HY-N2897 Dihydrokaempferol 99.92% Unkown
HY-155956 GM-90257 99.90% Unkown
HY-N3584 Paris saponin VII 99.84% Unkown
HY-128483 Fusaric acid 99.94% Unkown
HY-15531S Venetoclax-d8 99.76% Unkown
HY-113438 15(S)-HPETE 97.32% Unkown
HY-N0171R Beta-Sitosterol (Standard) Inducer 98.18% Unkown
HY-124284 Hexamethylene bisacetamide 99.56% Unkown
HY-N1255 Scoulerine 99.99% Unkown
HY-138832 BM-1244 99.83% Unkown
HY-N0559 Kirenol 99.82% Unkown
HY-N1423A Glycocholic acid sodium 97.0% Unkown
HY-159059 Ganoderma Lucidum/Reishi Extract 41.20% Unkown
HY-N1423S Glycocholic acid-d4 99.92% Unkown
HY-N12060 Ginkgo biloba extract Inhibitor / Unkown
HY-12875 BQU57 Inhibitor 98.47% Unkown
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% Unkown
HY-N0657 Pinoresinol Diglucoside 99.84% Unkown
HY-N1440 Koumine Activator 99.97% Unkown
HY-126437 Poly-L-lysine hydrobromide (MW 30000-70000) / Unkown
HY-N0674A Dehydrocorydaline chloride 99.75% Unkown
HY-125877 PROTAC Mcl1 degrader-1 Inhibitor 98.13% Unkown
HY-B1839 Fluazinam 99.51% Unkown
HY-P1527 Bim BH3 99.74% Unkown
HY-101259 BMS-195614 99.5% Unkown
HY-N7675 Flavanomarein Inhibitor 99.92% Unkown
HY-Y0315 Hexane-2,5-dione 99.96% Unkown
HY-12020 TW-37 Inhibitor 99.50% Unkown
HY-N6850 Calenduloside E 99.07% Unkown
HY-P2970 Stem bromelain / Unkown
HY-33350 Clofilium tosylate 99.60% Unkown
HY-N0392 Polygalasaponin F 99.85% Unkown
HY-P1889 Bim BH3, Peptide IV 99.24% Unkown
HY-153803 GBD-9 Degrader 99.91% Unkown
HY-N2067 Vanillyl alcohol Inhibitor 99.68% Unkown
HY-N6005 Methyl caffeate 99.89% Unkown
HY-P1380A Difopein TFA 95.35% Unkown
HY-15191 Sabutoclax Inhibitor 99.80% Unkown
HY-177306 Opitor-0 Inhibitor 98.02% Unkown
HY-N0863 Methyl protodioscin 99.67% Unkown
HY-N2132 Flavokawain B 99.99% Unkown
HY-N3009 Secoxyloganin 99.33% Unkown
HY-N6082 Rhein 8-O-β-D-Glucopyranoside Inhibitor 99.81% Unkown
HY-100383 BH3I-1 98.0% Unkown
HY-101310 SYM 2081 98.0% Unkown
HY-11095 NPS 2390 99.90% Unkown
HY-129700 MCL-1/BCL-2-IN-2 Inhibitor 99.05% Unkown
HY-N3031 Grosvenorine 99.64% Unkown
HY-N3405 Lariciresinol 99.46% Unkown
HY-133557 XZ739 99.08% Unkown
HY-12011 HA14-1 Inhibitor 98.0% Unkown
HY-157176 BAX-IN-1 Inhibitor 98.05% Unkown
HY-169266 BRD-K56819078 Inhibitor 99.93% Unkown
HY-N0566 23-Hydroxybetulinic acid 99.44% Unkown
HY-N0757 8-​O-​Acetylharpagide 99.75% Unkown
HY-N1983 Caudatin Inducer 99.95% Unkown
HY-139309 PROTAC Bcl-xL degrader-2 Inhibitor 98.23% Unkown
HY-120882 BM-1197 Inhibitor 99.48% Unkown
HY-101195 DL-erythro-Dihydrosphingosine Inhibitor 98.0% Unkown
HY-107835 Flumethrin 99.29% Unkown
HY-113471A (S)-(-)-Perillic acid 99.9% Unkown
HY-172209 PPIA-IN-1 96.90% Unkown
HY-N0307 Ciwujianoside B Inhibitor 99.68% Unkown
HY-N0674B Dehydrocorydaline (hydroxyl) 99.52% Unkown
HY-W013105 Sodium glycocholate hydrate, 98% 99.91% Unkown
HY-129681 MCL-1/BCL-2-IN-1 Inhibitor 98.65% Unkown
HY-162858 BRD-810 98.00% Unkown
HY-B0011S Docetaxel-d9 98.65% Unkown
HY-101997 BEPP hydrochloride 99.62% Unkown
HY-156278 FB49 Inhibitor 99.76% Unkown
HY-16014 A-385358 Inhibitor 95.10% Unkown
HY-161410 WH244 Degrader 99.82% Unkown
HY-N2135 Puerarin 6''-O-Xyloside 99.81% Unkown
HY-N2416 Taccalonolide A 99.29% Unkown
HY-N7930 Crenulatin 99.85% Unkown
HY-NP192 Sericin 0% Unkown
HY-119931 2-Hydroxychalcone 98.54% Unkown
HY-172798 XZ338 Degrader 98.17% Unkown
HY-179528 DIM-3,5-Cl2 99.18% Unkown
HY-N6576 Hellebrigenin 99.69% Unkown
HY-P2343 BH3 hydrochloride Activator 98.03% Unkown
HY-W674241 4-Ethylphenyl sulfate Inducer / Unkown
HY-N0853A Alisol A 24-acetate 98.0% Unkown
HY-P10336 Serpinin Agonist 98.74% Unkown
HY-142209 ABBV-167 Inhibitor 98.10% Unkown
HY-132307 Mcl-1 inhibitor 6 98.77% Unkown
HY-16967 MM41 98.89% Unkown
HY-101083 BDA-366 Antagonist 98.42% Unkown
HY-147929 Apoptotic agent-3 98.19% Unkown
HY-169265 BRD-K20733377 Inhibitor 99.50% Unkown
HY-167881 MLS-0053105 Inhibitor 98.89% Unkown
HY-10087S Navitoclax-d8 Inhibitor 99.71% Unkown
HY-111329 JGB1741 99.37% Unkown
HY-129702 MCL-1/BCL-2-IN-4 Inhibitor 99.95% Unkown
HY-147785 Pim-1 kinase inhibitor 2 99.91% Unkown
HY-156096 HDAC3-IN-2 / Unkown
HY-161100 BDM19 Inducer 99.38% Unkown
HY-B1752 Quinpirole 98.95% Unkown
HY-N0320 Salvianolic acid D 95.15% Unkown
HY-N1157 Thevetiaflavone 99.83% Unkown
HY-N1423B Glycocholic acid hydrate 99.85% Unkown
HY-N7905 Myricetin 3'-glucoside Inhibitor 99.98% Unkown
HY-N0882 Desacetylcinobufotalin 99.41% Unkown
HY-N1414A 3′,6-Disinapoylsucrose Inhibitor 98.88% Unkown
HY-N1930 (-)-Hinesol Inducer 98.7% Unkown
HY-Y0315S 2,5-Hexanedione-d10 98.55% Unkown
HY-111837 BI1071 / Unkown
HY-119979 Cardanol monoene Inducer 98.02% Unkown
HY-135273 A-1211212 98.43% Unkown
HY-161254 ATPase-IN-3 99.89% Unkown
HY-169925 BM-962 Inhibitor 99.10% Unkown
HY-B1900R Methylprednisolone succinate (Standard) 98.90% Unkown
HY-N4238 Dehydrocorydaline nitrate 99.89% Unkown
HY-109617 4-(4-Fluorophenyl)benzoic acid 99.01% Unkown
HY-N13250 Hawthorn Extract / Unkown
HY-N4308 Hexamethylquercetagetin Inhibitor 98.0% Unkown
HY-RS01415 BCL2 Human Pre-designed siRNA Set A / Unkown
HY-156620 Lacutoclax Inhibitor / Unkown
HY-175342 FCN-338 Inhibitor 99.33% Unkown
HY-19551 Apogossypolone 98.58% Unkown
HY-119833 Rubone Modulator 99.1% Unkown
HY-129179B (Rac)-Lisaftoclax Inhibitor 98.22% Unkown
HY-129488 FPFS-1169 hydrochloride Agonist 99.83% Unkown
HY-129701 MCL-1/BCL-2-IN-3 Inhibitor 98.93% Unkown
HY-133772 Venetoclax N-oxide 99.66% Unkown
HY-13408 (+)-Apogossypol Inhibitor / Unkown
HY-160108 Bcl-2-IN-17 Inhibitor / Unkown
HY-160921 Capeserod Agonist 98.66% Unkown
HY-161276 BFC1108 Inducer 98.11% Unkown
HY-161659 Apoptosis inducer 19 98.31% Unkown
HY-170820 XYD049 Inhibitor 99.46% Unkown
HY-174873 AF151 98.87% Unkown
HY-177102 Mesutoclax Inhibitor 98.69% Unkown
HY-N10144 Shinpterocarpin Inhibitor / Unkown
HY-N1423S1 Glycocholic acid-d5 99.9% Unkown
HY-N1983R Caudatin (Standard) Inducer 99.31% Unkown
HY-N2199 Sotetsuflavone 96.75% Unkown
HY-N6674 Diazepinomicin 98.04% Unkown
HY-N6690 Destruxin B 99.86% Unkown
HY-P1733 BMf-BH3 / Unkown
HY-P5325A Bid BH3 (80-99) acetate 98.13% Unkown
HY-RS01431 BCL2L13 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W073128 Perfluorotetradecanoic acid 98.0% Unkown
HY-W674241A 4-Ethylphenyl sulfate sodium Inducer / Unkown
HY-15191B (S)-Sabutoclax Inhibitor 98.03% Unkown
HY-B1559 Allethrin Inducer 98.04% Unkown
HY-N1218 Stellasterol Inhibitor / Unkown
HY-N16483 Procyanidin B2-3'-O-gallate / Unkown
HY-RS01421 BCL2L1 Human Pre-designed siRNA Set A / Unkown
HY-W075770 Nickel(II) oxide ≥99.0% Unkown
HY-10087A1 Navitoclax dihydrochloride / Unkown
HY-114310 VDR agonist 1 / Unkown
HY-131247 Bcl-2-IN-2 Inhibitor / Unkown
HY-141876 PRT543 / Unkown
HY-155188 NWP-0476 Inhibitor / Unkown
HY-100762 Mcl1-IN-11 Inhibitor / Unkown
HY-100763 Mcl1-IN-12 Inhibitor / Unkown
HY-146097 RMS5 / Unkown
HY-149918 Antiproliferative agent-23 / Unkown
HY-18106 BM 957 Inhibitor / Unkown
HY-184107 Bcl-2-IN-25 Inhibitor / Unkown
HY-101999 EM20-25 / Unkown
HY-107272 Chuanbeinone / Unkown
HY-107835R Flumethrin (Standard) / Unkown
HY-107835S Flumethrin-d5 / Unkown
HY-115974 GRPR antagonist-1 99.80% Unkown
HY-116204 SKLB70326 / Unkown
HY-116267 MHY219 / Unkown
HY-117171 Proquinazid / Unkown
HY-119062 A-800141 Inhibitor / Unkown
HY-121934 BH3I-2' / Unkown
HY-123020 CYD-2-88 Antagonist / Unkown
HY-123034 CDKI-83 / Unkown
HY-123244 YC137 / Unkown
HY-123715 Anticancer agent 255 / Unkown
HY-124122 BPTQ / Unkown
HY-124792 MRLB-223 / Unkown
HY-125191 BRD1991 Inhibitor / Unkown
HY-126311 4-Hydroxyresveratrol Inducer / Unkown
HY-127130 Spicamycin / Unkown
HY-131188 PROTAC Bcl-xL degrader-1 Inhibitor / Unkown
HY-131405 β-Eleostearic acid Inhibitor / Unkown
HY-135275 BCL-XL-IN-4 Inhibitor / Unkown
HY-136778 INH2BP / Unkown
HY-13846 BM-1074 / Unkown
HY-143235 BRD4 Inhibitor-15 / Unkown
HY-143872 Bcl-2-IN-4 Inhibitor / Unkown
HY-143873 Bcl-2-IN-5 Inhibitor / Unkown
HY-144428 Bcl-2/Mcl-1-IN-2 Inhibitor / Unkown
HY-144430 Bcl-2/Mcl-1-IN-1 Inhibitor / Unkown
HY-144431 Bcl-2/Mcl-1-IN-3 Inhibitor / Unkown
HY-144778 IDO1/TDO-IN-1 / Unkown
HY-144791 Bcl-2-IN-6 / Unkown
HY-144792 Bcl-2-IN-7 / Unkown
HY-145288 Antitumor agent-36 / Unkown
HY-145289 Antitumor agent-37 / Unkown
HY-146095 p53 Activator 2 / Unkown
HY-146253 CDK1/2/4-IN-1 / Unkown
HY-146444 Anticancer agent 56 / Unkown
HY-146471 EGFR-IN-51 / Unkown
HY-146472 EGFR-IN-52 / Unkown
HY-146817 Tubulin polymerization-IN-11 / Unkown
HY-147504 Anticancer agent 63 / Unkown
HY-147826 EGFR-IN-60 / Unkown
HY-147906 Anticancer agent 71 / Unkown
HY-147928 Apoptotic agent-2 / Unkown
HY-149009 Bcl-2-IN-9 / Unkown
HY-149024 VEGFR-2-IN-23 / Unkown
HY-149436 CDK2/Bcl2-IN-1 Inhibitor / Unkown
HY-149517 EGFR/BRAFV600E-IN-2 / Unkown
HY-149622 Bcl-2-IN-12 Inhibitor / Unkown
HY-149623 Bcl-2-IN-13 Inhibitor / Unkown
HY-149624 Bcl-2-IN-14 Inhibitor / Unkown
HY-149625 Bcl-2-IN-15 Inhibitor / Unkown
HY-149681 Beclin1-Bcl-2 interaction inhibitor 1 Inhibitor / Unkown
HY-150540 Bcl-2-IN-10 / Unkown
HY-150596 CT1-3 / Unkown
HY-151428 Antitumor agent-78 / Unkown
HY-151429 Antitumor agent-77 / Unkown
HY-151443 HDAC-IN-47 Inhibitor / Unkown
HY-153494 Rosomidnar Inhibitor / Unkown
HY-153494A Rosomidnar sodium Inhibitor / Unkown
HY-153953 Bcl-2-IN-11 Inhibitor / Unkown
HY-155242 VEGFR-2-IN-36 / Unkown
HY-159513 Bcl-2/Mcl-1-IN-4 Inhibitor / Unkown
HY-159668 DL002 / Unkown
HY-159817 Asaretoclax Inhibitor / Unkown
HY-159938 p38α inhibitor 6 / Unkown
HY-161415 BCL-xL/BCL-2 ligand 1 / Unkown
HY-161577 BFC1103 / Unkown
HY-161732 GQN-B37-E Inhibitor / Unkown
HY-161786 Bcl-2-IN-20 / Unkown
HY-162148 HNPMI Inhibitor 99.57% Unkown
HY-162820 Bcl-2-IN-21 Inhibitor / Unkown
HY-162826 Apoptosis inducer 27 Inducer / Unkown
HY-162886 BSO-07 Activator / Unkown
HY-163077 Anticancer agent 175 Inducer / Unkown
HY-163308 Bcl-2-IN-18 Inhibitor / Unkown
HY-163309 Bcl-2-IN-19 Inhibitor / Unkown
HY-163435 Anticancer agent 201 / Unkown
HY-163527 FGFR-IN-13 Inhibitor / Unkown
HY-163764 Bfl-1-IN-4 / Unkown
HY-167237 Calactin / Unkown
HY-167825 Barakol / Unkown
HY-168171 ERK1/2 inhibitor 11 / Unkown
HY-168483 FTO-IN-13 / Unkown
HY-168623 EGFR-IN-134 / Unkown
HY-169083 Bcl-2-IN-22 Inhibitor / Unkown
HY-169096 DPP-21 / Unkown
HY-169124 Apoptosis inducer 28 / Unkown
HY-169267 BRD-K44839765 Inhibitor / Unkown
HY-169412 MAPK-IN-3 / Unkown
HY-169431 VEGFR-2/AKT-IN-2 / Unkown
HY-170366 VEGFR-2-IN-58 / Unkown
HY-170648 TS-IN-5 / Unkown
HY-170689 CG-3-246 Inhibitor / Unkown
HY-170787 TZEP7 / Unkown
HY-170929 EMT inhibitor-3 / Unkown
HY-170932 EGFR/COX-2-IN-1 / Unkown
HY-170946 WR-S-462 Inhibitor / Unkown
HY-172092 BG11 Inducer / Unkown
HY-172393 TCF4/β-catenin-IN-1 / Unkown
HY-172394 ZSNI-21 / Unkown
HY-172551 anti-TNBC agent-9 / Unkown
HY-172623 EGFR/HER2-IN-17 / Unkown
HY-172886 PI3K-IN-58 / Unkown
HY-173365 VEGFR-2-IN-67 Inhibitor / Unkown
HY-174232 EGFR/CA-IX-IN-1 / Unkown
HY-174338 GPER/Bcl-2-IN-1 Inhibitor / Unkown
HY-174403 c-MYC/BCL2 ligand 1 iodide / Unkown
HY-174404 Topoisomerase II inhibitor 23 / Unkown
HY-174419 TFSeB / Unkown
HY-174469 PROTAC PI3K/110β degrader-2 / Unkown
HY-174855 PI3K/mTOR-IN-17 / Unkown
HY-174992 Apoptosis inducer 39 Inducer / Unkown
HY-175010 STAT3-IN-44 / Unkown
HY-175021 HDAC-IN-91 / Unkown
HY-175034 Topoisomerase I/II-IN-1 / Unkown
HY-175037 DNH28 / Unkown
HY-175227 STAT3/NF-κB-IN-1 / Unkown
HY-175317 Nogo-B-IN-1 / Unkown
HY-175332 Apoptosis inducer 43 / Unkown
HY-175397 Dth / Unkown
HY-175588 EGFR-IN-170 / Unkown
HY-175638 Carbonic anhydrase-IN-35 / Unkown
HY-175771 STAT3-IN-46 Inhibitor / Unkown
HY-175815 Apoptosis inducer 44 / Unkown
HY-175841 Tau Protein Phosphorylation-IN-1 Inhibitor / Unkown
HY-175848 NSC 850745 / Unkown
HY-176219 Bcl-2-IN-23 / Unkown
HY-176279 Hsp90-IN-42 Inhibitor / Unkown
HY-17662 Mol4 Inhibitor / Unkown
HY-177076 Dalvotoclax Inhibitor / Unkown
HY-177208 BW-AQ-113 / Unkown
HY-178008 Mcl-1-IN-16 / Unkown
HY-178036 ZM484 Inhibitor / Unkown
HY-178099 Apoptosis inducer 45 / Unkown
HY-178176 PROTAC CB1R Degrader-1 / Unkown
HY-178351 HDAC6-IN-67 / Unkown
HY-178373 Topoisomerase I-IN-18 / Unkown
HY-178380 HDAC8-IN-14 / Unkown
HY-178446 METTL3-IN-11 Inhibitor / Unkown
HY-178910 Mcl-1-IN-20 / Unkown
HY-178911 TS-IN-8 / Unkown
HY-178940 Apoptosis inducer 49 / Unkown
HY-178942 EGFR/VEGFR2-IN-9 / Unkown
HY-179125 COX-2-IN-59 / Unkown
HY-179155 PI3K/mTOR-IN-19 / Unkown
HY-179161 CDK2-IN-49 / Unkown
HY-179439 Multi-kinase-IN-8 / Unkown
HY-179480 G-quadruplex ligand 4 / Unkown
HY-179485 EGFR/VEGFR2-IN-10 / Unkown
HY-179520 XSJ151 / Unkown
HY-179522 EGFR-IN-186 / Unkown
HY-180154 EGFR/BRAFV600E-IN-6 / Unkown
HY-180190 Tubulin polymerization-IN-85 / Unkown
HY-180196 EGFR-IN-187 / Unkown
HY-180242 EGFR/CDK2-IN-5 / Unkown
HY-180245 STAT3-IN-51 / Unkown
HY-180274 JAK1/2-IN-3 / Unkown
HY-180324 Candidone / Unkown
HY-180618 p53 DUBTAC modulator-1 / Unkown
HY-180820 Dimethyl bisphenolate / Unkown
HY-180823 Topoisomerase II/EGFR-IN-2 / Unkown
HY-180848 Bcl-2-IN-24 / Unkown
HY-181015 α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu / Unkown
HY-181018 Topo I/DDX5-IN-1 / Unkown
HY-181060 Apoptosis inducer 56 / Unkown
HY-181061 COX/5-LO-IN-2 / Unkown
HY-181087 Anticancer agent 296 / Unkown
HY-181174 Antioxidant agent-22 / Unkown
HY-181413 PROTAC EZH2 Degrader-44 / Unkown
HY-181477 ERK5-IN-7 / Unkown
HY-181505 BRD4-IN-12 / Unkown
HY-181673 ICD inducer-2 / Unkown
HY-181723 Anticancer agent 304 / Unkown
HY-181725 Topoisomerase I-IN-20 / Unkown
HY-181746 Bcl-2/Mcl-1-IN-5 / Unkown
HY-181769 Anticancer agent 306 / Unkown
HY-181795 CSN5-IN-3 / Unkown
HY-182060 PDE4B/D-IN-5 / Unkown
HY-182069 CDK9-IN-47 / Unkown
HY-182243 HK2-IN-4 / Unkown
HY-182284 Anticancer agent 310 / Unkown
HY-182360 Cytisine-platinum(IV) prodrug-1 / Unkown
HY-182469 FuBIG / Unkown
HY-182706 NSC 373981 Inhibitor / Unkown
HY-182745 VEGFR-2-IN-85 / Unkown
HY-182759 MN33-47 / Unkown
HY-182760 MN33-63 / Unkown
HY-182763 EGFR/BRAFV600E-IN-7 / Unkown
HY-182986 LS-Q2 / Unkown
HY-183069 FKL-137 / Unkown
HY-183327 PI3K/mTOR-IN-22 Inhibitor / Unkown
HY-183330 Topo I/II-IN-3 / Unkown
HY-183355 KRAS G12D-IN-37 / Unkown
HY-183369 VEGFR/PD-L1-IN-1 / Unkown
HY-183791A Ferroptosis/apoptosis inducer-5 / Unkown
HY-184116 A2AR/EGFR-IN-1 / Unkown
HY-184145 AKT1-IN-13 / Unkown
HY-184302 Apoptosis inducer 62 / Unkown
HY-184443 Bcl-2-IN-26 / Unkown
HY-185559 Mito-fisetin mF7 / Unkown
HY-18628S UMI-77-d4 Inhibitor / Unkown
HY-50907S ABT-737-d8 99.11% Unkown
HY-B0011AS Docetaxel-d5 trihydrate / Unkown
HY-N0307R Ciwujianoside B (Standard) Inhibitor / Unkown
HY-N0361S Dihydrocapsaicin-d3 / Unkown
HY-N0392R Polygalasaponin F (Standard) Inhibitor / Unkown
HY-N0559R Kirenol (Standard) / Unkown
HY-N0757R 8-O-Acetylharpagide (Standard) / Unkown
HY-N10091 2,3-Dihydro-3α-methoxynimbolide / Unkown
HY-N10342 Cajanol / Unkown
HY-N1255A Scoulerine hydrochloride / Unkown
HY-N13338 Avicin D / Unkown
HY-N15449 Vicanicin / Unkown
HY-N16771 Clausenidin / Unkown
HY-N16929 Gymnoside II / Unkown
HY-N17440 2-Methoxyjuglone / Unkown
HY-N17617 S-Petasin / Unkown
HY-N17816 Tambulin / Unkown
HY-N20627 Withametelin B / Unkown
HY-N2741 Vitexin B-1 Inhibitor / Unkown
HY-N3828 epi-Eriocalyxin A / Unkown
HY-N6799 Neosolaniol 99.72% Unkown
HY-N7917 Tenacigenoside A / Unkown
HY-N9778 Phoyunbene B / Unkown
HY-P10057 cpm-1285 Inducer / Unkown
HY-P10058 cpm-1285m / Unkown
HY-P10833 C-VGB3 / Unkown
HY-P11374 Bid BH3-Gly-r8 Ligand / Unkown
HY-P11707 FS1 peptide / Unkown
HY-P1380 Difopein / Unkown
HY-P1889A Bim BH3, Peptide IV TFA / Unkown
HY-P5324 Bad BH3 (mouse) / Unkown
HY-P5325 Bid BH3 (80-99) / Unkown
HY-P5327 r8 Bid BH3 / Unkown
HY-RS01416 Bcl2 Mouse Pre-designed siRNA Set A / Unkown
HY-RS01417 BCL2 Rat Pre-designed siRNA Set A / Unkown
HY-RS01418 BCL2A1 Human Pre-designed siRNA Set A / Unkown
HY-RS01419 Bcl2a1 Rat Pre-designed siRNA Set A / Unkown
HY-RS01420 Bcl2a1a Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01422 Bcl2l1 Mouse Pre-designed siRNA Set A / Unkown
HY-RS01423 Bcl2l1 Rat Pre-designed siRNA Set A / Unkown
HY-RS01424 BCL2L10 Human Pre-designed siRNA Set A / Unkown
HY-RS01425 Bcl2l10 Mouse Pre-designed siRNA Set A / Unkown
HY-RS01426 Bcl2l10 Rat Pre-designed siRNA Set A / Unkown
HY-RS01427 BCL2L11 Human Pre-designed siRNA Set A / Unkown
HY-RS01428 Bcl2l11 Mouse Pre-designed siRNA Set A / Unkown
HY-RS01429 Bcl2l11 Rat Pre-designed siRNA Set A / Unkown
HY-RS01430 BCL2L12 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01432 BCL2L14 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01433 BCL2L15 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01434 BCL2L2 Human Pre-designed siRNA Set A / Unkown
HY-RS01435 Bcl2l2 Mouse Pre-designed siRNA Set A / Unkown
HY-RS01436 Bcl2l2 Rat Pre-designed siRNA Set A / Unkown
HY-W016937 Moroxydine Inhibitor / Unkown
HY-W713297 Moroxydine hydrochloride-d8 Inhibitor / Unkown
HY-W717425 SC-60 / Unkown
HY-W754548 Glycocholic acid-13C2,d4 / Unkown
HY-101083A (Rac)-BDA-366 Inhibitor / Unkown
HY-115529 (-)BI97D6 Inducer / Unkown
HY-116532 YCW-E11 Inhibitor / Unkown
HY-117136 AN-7 / Unkown
HY-12011A (Rac)-HA14-1 Inhibitor / Unkown
HY-122047 SW063058 / Unkown
HY-136714 Bcl-2-IN-3 Inhibitor / Unkown
HY-15531S1 Venetoclax-d6 / Unkown
HY-164468 Ch282-5 Inhibitor / Unkown
HY-171031 TFGF-18 / Unkown
HY-174635 Human IL15RA mRNA / Unkown
HY-174776 Human BAX mRNA / Unkown
HY-174777 Human BAK1 mRNA / Unkown
HY-181030 BDE30671203 / Unkown
HY-182586 Decyl gallate Activator / Unkown
HY-N15136 Isomorellinol Inducer / Unkown
HY-N15315 Triptriolide / Unkown
HY-N15378 β-Carotene-15,15'-epoxide / Unkown
HY-N15466 Longan cerebroside II Inhibitor / Unkown
HY-N18905 α-D-Glucosyl hesperidin / Unkown
HY-N6082R Rhein 8-O-β-D-Glucopyranoside (Standard) / Unkown
HY-N6799R Neosolaniol (Standard) / Unkown
HY-N6926 1,3,5-Tricaffeoylquinic acid / Unkown
HY-N8579 Eugenyl benzoate ≥90.0% Unkown
HY-RS21989 Bcl2l12 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS28507 Bcl2l12 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W715812 Bromuconazole / Unkown
HY-W747601 Chlorphoxim / Unkown
HY-W751400 Solasodine hydrochloride / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990344 Anti-Bcl-2 Antibody Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens BCL2 NCBI NCBI:596
Mus musculus BCL2 NCBI NCBI:12043
Rattus norvegicus BCL2 NCBI NCBI:24224